Rockwell Medical (NASDAQ: RMTI) — Perfil da empresa, notícias e dados financeiros
Rockwell Medical (NASDAQ:RMTI) develops biopharmaceutical products for end-stage renal disease and chronic kidney disease treatments.
Rockwell Medical
Rockwell Medical (NASDAQ:RMTI) is a biopharmaceutical company primarily engaged in the development, manufacture, and distribution of products targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD). Its portfolio includes innovative dialysis concentrates, iron therapies, and medical delivery systems that aim to improve the quality of care and life for patients undergoing dialysis treatment. Rockwell Medical focuses on advancing renal disease treatments through research and innovation, aiming to address the unmet medical needs within the kidney health space. With a commitment to enhancing patient outcomes and expanding its product offerings, Rockwell Medical strives to be at the forefront of kidney health solutions.
Resumo
Operações
Produtos e/ou serviços de Rockwell Medical
- Triferic, an FDA-approved iron replacement and hemoglobin maintenance drug for chronic kidney disease patients on dialysis.
- Calcitriol, a generic vitamin D analogue capsule for managing hypocalcemia in patients undergoing chronic renal dialysis.
- Dialysate concentrates used in hemodialysis treatment for patients with chronic kidney failure.
- RenalPure and SteriLyte, bicarbonate concentrates designed for use in dialysis treatment, aiding in patient blood purification.
- Citrapure, a citrate-based dialysate for reducing systemic inflammation and improving biocompatibility in dialysis treatments.
- Drugs in development aiming at improving iron delivery and management in patients with various stages of chronic kidney disease.
equipe executiva do Rockwell Medical
- Mark StrobeckPresident, CEO & Director
- Jesse NeriSenior VP & CFO
- Megan C. TimminsExecutive VP, Chief Legal Officer & Secretary
- Heather H. HunterSenior VP & COO
- Nicholas FanslauController & Principal Accounting Officer
- Timothy T. CholeSenior VP & Chief Commercial Officer
Últimas notícias sobre a Rockwell Medical
Principais indicadores financeiros
Resultados divulgados pela Rockwell Medical, em USD.
- Cap. de mercado
- 29,5 mi
- Receita (TTM)
- 69,4 mi
- P/L
- —
- LPA (diluído, TTM)
- -1.3
- Dividend yield
- —
- Margem de lucro
- -7.3%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 69,3 mi | -4,7 mi | -5,3 mi | |
| 101,5 mi | 608 mil | -480 mil | |
| 83,6 mi | -6,7 mi | -8,4 mi | |
| 72,8 mi | -16,8 mi | -18,7 mi |